RAC 2.20% $1.78 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-68

  1. 146 Posts.
    lightbulb Created with Sketch. 642
    https://hotcopper.com.au/data/attachments/5715/5715233-8fe5884828611e976dce7e8c6d80b8eb.jpg

    You can see the previous lines of therapy these patients had used in the announement. A number of these therapies would be considered chemotherapy includng cytarabine/dauno, idarubicine and fludarabine. Venetoclax, gilteritinib and the CAR-T would probably not be considered "chemotherapy" although the term is a bit vague.
    Last edited by JBeez_: 07/11/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.